Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-30

FDA Approved: DOFETILIDE 0.125MG — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for dofetilide 0.125 mg (granules) by Granules Pharmaceuticals Inc., expanding the product's available strength/formulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dofetilide (dofetilide)

Snippet

SUPPL AP for DOFETILIDE 0.125MG (DOFETILIDE 0.125MG)